PlainRecalls
FDA Drug Low Class III Terminated

Bekyree (desogestrel and ethinyl estradiol tablets USP, 0.15 mg/0.02 mg and ethinyl estradiol tablets USP, 0.01 mg), packaged in 1 Wallet of 28 Tablets (NDC 68180-879-11), 3 Wallets of 28 Tablets Each per carton (NDC 68180-879-13), Rx Only, Distributed by: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Pithampur (M.P.) - 454775, INDIA.

Reported: March 18, 2020 Initiated: March 9, 2020 #D-1055-2020

Product Description

Bekyree (desogestrel and ethinyl estradiol tablets USP, 0.15 mg/0.02 mg and ethinyl estradiol tablets USP, 0.01 mg), packaged in 1 Wallet of 28 Tablets (NDC 68180-879-11), 3 Wallets of 28 Tablets Each per carton (NDC 68180-879-13), Rx Only, Distributed by: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Pithampur (M.P.) - 454775, INDIA.

Reason for Recall

Failed Content Uniformity Specifications: Out Of Specification test results observed for content and blend uniformity.

Details

Units Affected
1,712 cartons
Distribution
Nationwide in the USA and Puerto Rico.
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Bekyree (desogestrel and ethinyl estradiol tablets USP, 0.15 mg/0.02 mg and ethinyl estradiol tablets USP, 0.01 mg), packaged in 1 Wallet of 28 Tablets (NDC 68180-879-11), 3 Wallets of 28 Tablets Each per carton (NDC 68180-879-13), Rx Only, Distributed by: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Pithampur (M.P.) - 454775, INDIA.. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 1,712 cartons.
Why was this product recalled?
Failed Content Uniformity Specifications: Out Of Specification test results observed for content and blend uniformity.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 18, 2020. Severity: Low. Recall number: D-1055-2020.